Zobrazeno 1 - 10
of 4 002
pro vyhledávání: '"Hbsag prevalence"'
Autor:
Komada, Kenichi, Ichimura, Yasunori, Shimada, Mami, Funato, Masafumi, Do, Hung Thai, LE, Huy Xuan, Hoang, Thanh Tien, Nguyen, Trieu Bao, Huynh, Mai Kim, Hoang, Hang Thi Hai, Tran, Nhu Anh Thi, LE, Thieu Hoang, Ngo, Quyet Thi, Miyano, Shinsuke, Sugiyama, Masaya, Mizoue, Tetsuya, Hachiya, Masahiko
Publikováno v:
In Journal of Virus Eradication December 2022 8(4)
Publikováno v:
Clinical and Research Journal in Internal Medicine, Vol 4, Iss 1, Pp 373-383 (2023)
Background: Hepatitis B is the most common chronic viral infection and a significant contributor to morbidity and death globally. Based on the mother's hepatitis B e antigen (HBeAg) status, the probability of perinatal HBV infection in children deliv
Externí odkaz:
https://doaj.org/article/fb75335a16d94d12b331502176915fdd
Autor:
Kenichi Komada, Yasunori Ichimura, Mami Shimada, Masafumi Funato, Hung Thai Do, Huy Xuan LE, Thanh Tien Hoang, Trieu Bao Nguyen, Mai Kim Huynh, Hang Thi Hai Hoang, Nhu Anh Thi Tran, Thieu Hoang LE, Quyet Thi Ngo, Shinsuke Miyano, Masaya Sugiyama, Tetsuya Mizoue, Masahiko Hachiya
Publikováno v:
Journal of Virus Eradication, Vol 8, Iss 4, Pp 100309- (2022)
Background: Vietnam introduced a 3-dose hepatitis B (HBV) immunization program comprising 1 dose immediately after birth and 2 or 3 in infancy in the past 20 years, but the impact of the vaccine has not been systematically evaluated. Thus, we conduct
Externí odkaz:
https://doaj.org/article/38634b549e6f418babad3128fe7fe576
Publikováno v:
European Journal of Epidemiology, 1992 Jan 01. 8(1), 88-92.
Externí odkaz:
https://www.jstor.org/stable/3520775
Publikováno v:
Hepatitis Monthly. Mar2016, Vol. 16 Issue 3, p1-12. 12p.
Autor:
Adouani, B.1,2, Alami, R.1, Laouina, A.1,2, Benahadi, A.1,2, Boulahdid, S.1,2, Mokhtari, A.2, Soulaymani, A.2, Abouyoub, A.1, Benajiba, M.1
Publikováno v:
Transfusion Medicine. Dec2013, Vol. 23 Issue 6, p432-437. 6p.
Publikováno v:
American Journal of Gastroenterology. 105:1102-1109
Mortality and hepatitis B surface antigen (HBsAg) seroclearance are the two extremes of prognostic destination of chronic hepatitis B virus (HBV) infection. Their relative roles in the decline of HBsAg prevalence with increasing age are unknown.HBsAg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed7fc7e0877d4e1b614847d11da76e71
https://doi.org/10.1038/ajg.2009.669
https://doi.org/10.1038/ajg.2009.669
Autor:
Hamilton, Elizabeth Mova1 (AUTHOR) elizabeth.hamilton@ndph.ox.ac.uk, Rassam, Wadie2 (AUTHOR), Yan, Yan3 (AUTHOR), Singh, Avjit4 (AUTHOR), Ng, Sarah Yoon Ai1 (AUTHOR), Zhang, Jiabi5 (AUTHOR), Lv, Jun6,7 (AUTHOR), Islam, Nazrul1,8,9 (AUTHOR), Malouf, Reem8 (AUTHOR), Yang, Ling1,10 (AUTHOR) ling.yang@ndph.ox.ac.uk, Millwood, Iona Y.1,10 (AUTHOR), Chen, Zhengming1 (AUTHOR)
Publikováno v:
Journal of Viral Hepatitis. Jun2023, Vol. 30 Issue 6, p470-488. 19p.
Autor:
Abdelghani Mokhtari, A. Benahadi, S. Boulahdid, B. Adouani, M. Benajiba, A. Laouina, Ahmed Abouyoub, R. Alami, Abdelmajid Soulaymani
Publikováno v:
Transfusion Medicine. 23:432-437
SUMMARY Objectives To calculate the hepatitis B surface antigen (HBsAg) reactive rate for 2011 blood donors (BD) across Morocco. In addition, to monitor the profile of donors bearing the HBsAg during 2000 and 2011, we calculated the percentage of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4fc65eda040a568cbd023026c5501655
https://doi.org/10.1111/tme.12054
https://doi.org/10.1111/tme.12054
Publikováno v:
Hepatitis Monthly
Context The world health organization (WHO) recommends that all blood donations should be screened for evidence of infections, such as hepatitis B. The present study aimed to determine the prevalence of hepatitis B surface antigen (HBsAg) in blood do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9186c3a6902fbd638e52af0f2a9c2b26
https://pubmed.ncbi.nlm.nih.gov/27226804
https://pubmed.ncbi.nlm.nih.gov/27226804